Lipelis, Konstantin

Lipelis, Konstantin was paid $424K by Medicaid between Jan 2018 and Nov 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 70% of everything it billed.

33Billing provider infoLIPELIS, KONSTANTIN
ROCK HILL, NY 12775

33aNPI1548423809assigned 07/08/2008

33bProvider typePhysical Medicine & Rehabilitation Physician

28Total paid$424K

24GClaims5,537

24DCodes billed7

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Physical Medicine & Rehabilitation Physician providers in New York

Rank by total paid#52 of 465

Median peer was paid$12K

This provider vs. median35×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	530	$24K
2019	791	$53K
2020	777	$61K
2021	1,013	$106K
2022	1,462	$137K
2023	522	$28K
2024incomplete	442	$16K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	70%	3,577	3,527	$298K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	1,104	1,095	$64K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	5.2%	199	199	$22K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.9%	116	116	$16K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.8%	262	262	$16K
99442		1.4%	98	98	$6K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	181	180	$943.42

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.